Skip to main content
. 2023 Feb 23;7(13):3146–3149. doi: 10.1182/bloodadvances.2022009039

Table 1.

Patient characteristics

N = 120 (range), (%)
Median age at enrollment (y) 59 (24-89)
Female 58 (48.0)
Race
 Non-Hispanic White 77 (64.0)
 Hispanic 14 (11.7)
 Asian 11 (9.2)
 Black 8 (6.7)
Cancer type
 Myeloma 50 (41.7)
 Non-indolent lymphoma 21 (17.5)
 Acute myeloid leukemia 18 (15.0)
 Myeloproliferative neoplasm 14 (11.7)
Reasons for referral
 Pain 72 (60.0)
 Mood 15 (12.5)
 Fatigue 9 (7.5)
 Goals of care conversations before HSCT 12 (10.0)
Reasons for hospitalization Before PC After PC
Chemotherapy/radiotherapy 21 10
Pain 7 4
New cancer diagnosis 3 0
Relapsed disease 3 0
Orthopedic procedure 2 1
Hernia 2 0
Biopsy 2 0
Viral upper respiratory infection 2 2
Treatment toxicity 1 0
Gastric anastomotic leak 1 0
Pacemaker placement 1 0
Myocardial infarction 1 0
Dysphagia 1 0
Fever 1 5
Bowel ischemia 1 0
Nausea/vomiting 1 1
Gastrointestinal bleeding 1 1
Failure to thrive 1 0
Altered mental status 1 0
Bacterial infection 0 3
Disease progression 0 2
Subdural hematoma 0 1
Adrenal insufficiency 0 1
Acute kidney injury 0 1